298 related articles for article (PubMed ID: 17979695)
1. Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke.
Mukhopadhyay S; Tulis DA
Cardiovasc Hematol Agents Med Chem; 2007 Oct; 5(4):311-8. PubMed ID: 17979695
[TBL] [Abstract][Full Text] [Related]
2. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.
Fride E
Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy.
Romigi A; Bari M; Placidi F; Marciani MG; Malaponti M; Torelli F; Izzi F; Prosperetti C; Zannino S; Corte F; Chiaramonte C; Maccarrone M
Epilepsia; 2010 May; 51(5):768-72. PubMed ID: 19817812
[TBL] [Abstract][Full Text] [Related]
4. Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure.
Weis F; Beiras-Fernandez A; Sodian R; Kaczmarek I; Reichart B; Beiras A; Schelling G; Kreth S
J Mol Cell Cardiol; 2010 Jun; 48(6):1187-93. PubMed ID: 19931541
[TBL] [Abstract][Full Text] [Related]
5. An Introduction to the Endogenous Cannabinoid System.
Lu HC; Mackie K
Biol Psychiatry; 2016 Apr; 79(7):516-25. PubMed ID: 26698193
[TBL] [Abstract][Full Text] [Related]
6. Anandamide receptor signal transduction.
Goodfellow CE; Glass M
Vitam Horm; 2009; 81():79-110. PubMed ID: 19647109
[TBL] [Abstract][Full Text] [Related]
7. The role of the pancreatic endocannabinoid system in glucose metabolism.
Bermúdez-Silva FJ; Suárez Pérez J; Nadal A; Rodríguez de Fonseca F
Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):87-102. PubMed ID: 19285263
[TBL] [Abstract][Full Text] [Related]
8. The phylogenetic distribution and evolutionary origins of endocannabinoid signalling.
Elphick MR; Egertová M
Handb Exp Pharmacol; 2005; (168):283-97. PubMed ID: 16596778
[TBL] [Abstract][Full Text] [Related]
9. An introduction to the endocannabinoid system: from the early to the latest concepts.
De Petrocellis L; Di Marzo V
Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):1-15. PubMed ID: 19285257
[TBL] [Abstract][Full Text] [Related]
10. Opposing roles of CB
Gobira PH; Oliveira AC; Gomes JS; da Silveira VT; Asth L; Bastos JR; Batista EM; Issy AC; Okine BN; de Oliveira AC; Ribeiro FM; Del Bel EA; Aguiar DC; Finn DP; Moreira FA
Br J Pharmacol; 2019 May; 176(10):1541-1551. PubMed ID: 30101419
[TBL] [Abstract][Full Text] [Related]
11. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
McCollum L; Howlett AC; Mukhopadhyay S
J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
[TBL] [Abstract][Full Text] [Related]
12. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
[TBL] [Abstract][Full Text] [Related]
13. The critical role of the endocannabinoid system in emotional homeostasis: avoiding excess and deficiencies.
Marco EM; Viveros MP
Mini Rev Med Chem; 2009 Oct; 9(12):1407-15. PubMed ID: 19929814
[TBL] [Abstract][Full Text] [Related]
14. Anandamide initiates Ca(2+) signaling via CB2 receptor linked to phospholipase C in calf pulmonary endothelial cells.
Zoratti C; Kipmen-Korgun D; Osibow K; Malli R; Graier WF
Br J Pharmacol; 2003 Dec; 140(8):1351-62. PubMed ID: 14645143
[TBL] [Abstract][Full Text] [Related]
15. A role for 2-arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy.
Eisenstein SA; Clapper JR; Holmes PV; Piomelli D; Hohmann AG
Pharmacol Res; 2010 May; 61(5):419-29. PubMed ID: 20044005
[TBL] [Abstract][Full Text] [Related]
16. 2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts.
Wagner JA; Abesser M; Harvey-White J; Ertl G
J Cardiovasc Pharmacol; 2006 May; 47(5):650-5. PubMed ID: 16775503
[TBL] [Abstract][Full Text] [Related]
17. A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease.
van der Stelt M; Fox SH; Hill M; Crossman AR; Petrosino S; Di Marzo V; Brotchie JM
FASEB J; 2005 Jul; 19(9):1140-2. PubMed ID: 15894565
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid receptor subtype influence on neuritogenesis in human SH-SY5Y cells.
Lyons EL; Leone-Kabler S; Kovach AL; Thomas BF; Howlett AC
Mol Cell Neurosci; 2020 Dec; 109():103566. PubMed ID: 33049367
[TBL] [Abstract][Full Text] [Related]
19. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of allergic contact dermatitis through the endocannabinoid system.
Karsak M; Gaffal E; Date R; Wang-Eckhardt L; Rehnelt J; Petrosino S; Starowicz K; Steuder R; Schlicker E; Cravatt B; Mechoulam R; Buettner R; Werner S; Di Marzo V; Tüting T; Zimmer A
Science; 2007 Jun; 316(5830):1494-7. PubMed ID: 17556587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
